24
1 冠脂妥 膜衣錠 51020 毫克 CRESTOR 5, 10, 20mg Film-Coated Tablets 衛署藥輸字第 024597 衛署藥輸字第 024131 衛署藥輸字第 024129 1.【適應症】高膽固醇血症,高三酸甘油酯血症 說明 CRESTOR 適用於 1.1 作為飲食控制的輔助治療,可以降低原發性高膽固醇血症(異型接合子家族型 及非家族型)及混合型高脂血症(Fredrickson IIa 型及 IIb )患者已升高的總膽固 醇、低密度脂蛋白膽固醇(LDL-C) 、脂蛋白元 B(Apo B) 、非高密度脂蛋白膽固醇 及三酸甘油酯濃度,並且增加高密度脂蛋白膽固醇(HDL-C)患有異型接合子家族型高膽固醇血症(heterozygous familial hypercholesterolemiaHeFH)10-17 歲小兒患者 患有異型接合子家族型高膽固醇血症的 10-17 歲青少年及月經來潮至少一年的少 女,如果經過充分的飲食控制試驗後,仍有下列現象:低密度脂蛋白膽固醇>190 mg/dL,或>160 mg/dL 且有早發性心血管疾病的(CVD)家族史或有兩種或更多別 CVD 危險因子,可使用 CRESTOR 作為飲食控制的輔助治療,降低總膽固醇、 低密度脂蛋白膽固醇、脂蛋白元 B 濃度。 在青少年之臨床試驗中 CPK10 升高之比例高於成人。 1.2 作為飲食控制的輔助治療,治療血清三酸甘油酯濃度已升高的患者 (Fredrickson IV )1.3 原發性 β 血脂蛋白異常(第三型高乳糜粒血症) CRESTOR 可作為飲食控制的輔助治療,治療患有原發性 β 血脂蛋白異常(III 高乳糜粒血症)的病人。 1.4 作為其他降血脂治療(例如低密度脂蛋白血漿析離術[LDL apheresis])的輔助治 療,或不能做前述治療時的輔助治療,降低同型接合子家族型高膽固醇血症患者 的低密度脂蛋白膽固醇、總膽固醇及脂蛋白元 B(Apo B)根據美國國家膽固醇教育計畫第三版成人治療流程(NCEP-ATP III)指導方針,對 於有高膽固醇血症因而動脈粥樣硬化性血管疾病風險升高的患者,降血脂劑治療 應該是多重危險因子介入的一部分。降低低密度脂蛋白治療的兩種主要方法乃是 治療式生活型態改變(TLC)與藥物治療。治療式生活型態改變的飲食強調減少飽 和脂肪及膽固醇的攝取量。表 1 界定了低密度脂蛋白膽固醇的治療目標與開始 治療式生活型態改變及需要考慮藥物治療的分界點。

Crestor 5mg, 10mg, 20mg Film-Coated Tablets (PDF 708kb)

Embed Size (px)

Citation preview

  • 1

    51020

    CRESTOR 5, 10, 20mg Film-Coated Tablets 024597

    024131 024129

    1. CRESTOR 1.1 ()(Fredrickson IIa IIb )(LDL-C) B(Apo B)(HDL-C) (heterozygous familial hypercholesterolemiaHeFH) 10-17 10-17>190 mg/dL>160 mg/dL (CVD) CVD CRESTOR B CPK10 1.2 (Fredrickson IV )

    1.3 ()

    CRESTOR (III )

    1.4([LDL apheresis])

    B(Apo B)

    (NCEP-ATP III)

    (TLC) 1

  • 2

    1. (NCEP)

    CHDaCHD

    (10 20%)100 mg/dL 100 mg/dL

    130 mg/dL (100-129 mg/dL )b

    2 (10 20%)

    130 mg/dL 130 mg/dL

    10 10%-20% 130 mg/dL

    10 10% 160 mg/dL

    0-1 c 160 mg/dL 160 mg/dL 190 mg/dL

    (160-189 mg/dL)

    a CHD b100 mg/dL

    nicotinic acid fibrate

    c 0-1 10 10% 0-1 10

    200 mg/dL()

    30 mg/dL 130 mg/dL( NCEP ) 20 5 CRESTOR (

    )400 mg/dL(4.5 mmol/L) (0.20[]) 400 mg/dL (4.5 mmol/L)

  • 3

    CRESTOR Fredrickson I III V 2. 2.1 CRESTOR CRESTOR

    ()(Fredrickson IIa IIb ) CRESTOR 5-20 mg CRESTOR 10 mg 5 mg cyclosporine ()(190 mg/dL) 20 mg CRESTOR / 2-4

    statin statin CRESTOR CRESTOR

    CRESTOR/ 2-4

    2.2 10-17 CRESTOR 5-20 mg 20 mg( 20 mg )((12)(1.2)) 4

    2.3 CRESTOR 20 mg CRESTOR ([LDL apheresis])

    2.4 5 mg CRESTOR 5 10 mg

    rosuvastatin (:/::)

  • 4

    2.5 CyclosporineAtazanavir/RitonavirLopinavir/Ritonavir Simeprevir cyclosporine CRESTOR 5 mg ((5.1)(7.1) atazanavir ritonavir, lopinavir ritonavir simeprevir CRESTOR 10 mg ((5.1)(7.3))

    2.6 CRESTOR gemfibrozil CRESTOR 10 mg (:/:)

    2.7 (CLcr30 mL/min/1.73 m2)CRESTOR 5 mg 10 mg () 3. 5 10 20 4. CRESTOR CRESTOR ((6.1)) (hepatic transaminase)((5.2)) HMG-CoA

    ((8.1)(13.2)) HMG-CoA

    CRESTOR ((8.3))

    5.

    5.1 HMG-CoA ( CRESTOR)(myoglobinuria)

  • 5

    (rhabdomyolysis)(myopathy)(40mg) CRESTOR (65 ) CRESTOR (fibrates niacin), gemfibrozil, cyclosporine, atazanavir/ritonavir, lopinavir/ritonavir, simeprevir ((2)(7)) (creatinine kinase) CRESTOR ()CRESTOR IMNM statin IMNM statin

    CRESTOR 5.2

    12 () HMG-CoA CRESTOR[AST(SGOT) or ALT(SGPT)]

    CRESTOR CRESTOR 1.1%(ULN) 3 0.5%

  • 6

    ALT AST UTN 3 CRESTOR

    CRESTOR /((12.3))CRESTOR((4))

    5.3 Coumarin CRESTOR coumarin (the prothrombin time/INR) coumarin CRESTOR CRESTOR INR INR INR ((7.4)) 5.4 CRESTOR CRESTOR (dipstick-positive proteinuria)(microscopic hematuria) CRESTOR HMG-CoA CRESTOR 40 mg

    / CRESTOR 5.5 (HbA1c): HMG-CoA (statin )/ HMG-CoA ( CRESTOR) HbA1c ((6.1)) CRESTOR (cortisol)(adrenal reserve) CRESTOR ( ketoconazolespironolactonecimetidine) 5.6 statin (:)( 1 3 ) 6. *()((5.1)) *((5.2))

  • 7

    5,394 15 CRESTOR () 1.4% * * * CRESTOR 5,394 (2%) * * * * * 6.1

    2% 2 12 2 2% CRESTOR *(%) CRESTOR

    5 mg

    N=291

    CRESTOR 10 mg

    N=283

    CRESTOR 20 mg

    N=64

    CRESTOR 40 mg

    N=106

    Total CRESTOR 5 mg - 40 mg

    N=744

    N=382

    5.5 4.9 3.1 8.5 5.5 5.0

    3.8 3.5 6.3 0 3.4 3.1 3.1 2.1 6.3 1.9 2.8 1.3

    2.4 3.2 4.7 0.9 2.7 2.6 2.1 2.1 4.7 2.8 2.4 2.4

    * COSTART ()((5.4)) (glutamyl transpeptidase) (alkaline phosphatase)(bilirubin) METEOR 981 rosuvastatin 40mg(n=700)

  • 8

    (n=281) 1.7 5.6%CRESTOR 2.8%

    ((14.7)) 2% 3 3 METEOR 2% CRESTOR *(%)

    CRESTOR 40 mg

    N=700

    N=281

    12.7 12.1

    10.1 7.1

    6.4 5.3

    4.0 2.8

    Blood CPK 2.6 0.7

    2.4 1.8

    ALT >3x ULN 2.2 0.7 * MedDRA CPK: creatine phosphokinase, ULN: upper limit of normal JUPITER 17,802 rosuvastatin 20 mg(n=8901) (n=8901) 2 rosuvastatin 6.6% 6.2% JUPITER rosuvastatin (2.8%)(2.3%)Rosuvastatin HbA1c 0.1%rosuvastatin HbA1c > 6.5%((5.5)(14.8)) 2% 4 4 JUPITER CRESTOR *2% (%)

  • 9

    CRESTOR 20 mg N=8901

    N=8901

    7.6 6.6 3.8 3.2 3.3 3.0 2.4 2.3 * MedDRA

    6.2 10-17 rosuvastatin (CK)>10 x ULN rosuvastatin 130 4 (3%2 10 mg 2 20 mg ) CK > 10 x ULN 46 ((14.6)(8.4) 6.3 CRESTOR ()

    statin ((5.1)) 7.

    7.1 Cyclosporine Cyclosporine rosuvastatin (AUC) 7 cyclosporineCRESTOR 5mg ((5.1)(12.3)) 7.2 Gemfibrozil Gemfibrozil rosuvastatin / CRESTOR gemfibrozilCRESTOR 10mg ((12.3))

  • 10

    7.3 Rosuvastatin rosuvastatin Simeprevir ( C ) atazanavir/ritonavir lopinavir/ritonavir HIV-1 rosuvastatin (AUC) 3 ( 4 (12.3))CRESTOR 10 mg Fosamprenavir/ritonavir tipranavir/ritonavir HIV-1 rosuvastatin rosuvastatin ((2.5)(5.1)(12.3)) HIV boceprevirtelaprevir nefazodone 7.4 Coumarin CRESTOR coumarin INR CRESTOR coumarin CRESTOR coumarin INR CRESTOR INR ((5.3)(12.3)) 7.5 Niacin CRESTOR niacin (1 g/) CRESTOR ((5.1)) 7.6 Fenofibrate CRESTOR fenofibrate (AUC) HMG-CoA fenofibrates CRESTOR fenofibrates ((5.1)(12.3)) 7.8 Fusidic Acid rosuvastatin fusidic acid statins rosuvastatin fusidic acid rosuvastatin fusidic acid rosuvastatin 8.

    8.1 X CRESTOR

  • 11

    ((4)) CRESTOR HMG-CoA 100 HMG-CoA / 3~4 89% Rosuvastatin 40mg CRESTOR 40mg 10~12 40mg CRESTOR ((13.2)) CRESTOR CRESTOR

    8.3 rosuvastatin rosuvastatin

    HMG-CoA CRESTOR ((4)) 8.4 CRESTOR 10-17 12 40 CRESTOR 5 mg10 mg 20 mg ((6.2))

    (10-17 )CRESTOR BMI()((14.5)) CRESTOR ((8.1))CRESTOR 10 20 mg 8 (8) 18 (9 9 ) 10 17

  • 12

    CRESTORRosuvastatin (Cmax ) AUC 8.5 CRESTOR 10,275 3,159 (31%) 65 698 (6.8%) 75

    CRESTOR((5.1)(12.3)) 8.6 (CLcr30 mL/min/1.73m2) rosuvastatin (CLcr30 mL/min/1.73 m2)rosuvastatin

    CRESTOR ((5.1)(12.3)) 8.7 CRESTOR () rosuvastatin CRESTOR ((4)(5.2)(12.3)) 8.8 2 CRESTOR ((12.3)) 10.

    rosuvastatin

    11. CRESTOR (rosuvastatin calcium)Rosuvastatin calcium bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl) amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt

  • 13

    N

    N

    F

    NSO2Me

    OH OH

    O

    O

    Ca2+

    2 Rosuvastatin calcium (C22 H27 FN3 O6 S)2 Ca 1001.14Rosuvastatin calcium Rosuvastatin pH 7.0 -(octanol/water) 0.13 CRESTOR 510 20 mg rosuvastatin(tribasic calcium phosphate)crospovidone(hypromellose)(triacetin) 12.

    12.1 CRESTOR HMG-CoA 3-hydroxy-3- methylglutaryl coenzyme A mevalonate mevalonate rosuvastatin rosuvastatin

    12.3 3-5 rosuvastatin CRESTOR Cmax AUC CRESTOR 20% CRESTOR rosuvastatin AUC Rosuvastatin

  • 14

    Rosuvastatin 134 88% rosuvastatin (albumin) Rosuvastatin 10% N-desmethyl rosuvastatin P450 2C9 N-desmethyl rosuvastatin HMG-CoA rosuvastatin 1/6 ~ 1/2 HMG-CoA 90% rosuvastatin rosuvastatin(90%)Rosuvastatin 19 28%72% ()(AUC C max) 2 rosuvastatin (65 )rosuvastatin (CLcr30 mL/min/1.73m2) rosuvastatin (CLcr30 mL/min/1.73 m2) rosuvastatin (CLcr80 mL/min/1.73m2) 3 rosuvastatin (steady-state plasma concentration) 50% rosuvastatin Child-Pugh A Cmax AUC 60%5% Child-Pugh B Cmax AUC 100% 21% RosuvastatinP450 3A4 Rosuvastatin 1B1OATP1B1BCRPCRESTOR cyclosporine HIV

  • 15

    rosuvastatin () CRESTOR 5 Rosuvastatin Rosuvastatin

    (/)

    = 1.0

    (mg)1 AUC 1 Cmax

    Cyclosporine stable dose required

    (75 mg 200 mg BID)

    10 mg QD for

    10 days 7.12 112

    Atazanavir/ritonavir combination 300 mg/100 mg

    QD for 8 days 10 mg 3.12 72

    Simeprevir 150 mg QD, 7 days 10 mg,

    2.82

    (2.3-3.4)3

    3.22

    (2.6-3.9)3

    Lopinavir/ritonavir combination

    400 mg/100 mg BID for 17 days

    20 mg QD for

    7 days

    2.12

    (1.7-2.6)3

    52

    (3.4-6.4)3

    Clopidogrel 300 mg loading, followed by 75 mg at

    24 hours 20 mg 2 2

    Gemfibrozil 600 mg BID for 7 days 80 mg

    1.92

    (1.6-2.2)3

    2.22

    (1.8-2.7)3

    Eltrombopag 75 mg QD, 5 days 10 mg

    1.6

    (1.4-1.7)3

    2

    (1.8-2.3)3

    Darunavir 600 mg/ritonavir 100 mg

    BID, 7 days

    10 mg QD for

    7 days

    1.5

    (1.0-2.1)3

    2.4

    (1.6-3.6)3

    Tipranavir/ritonavir combination 500 mg/200mg

    BID for 11 days 10 mg

    1.4

    (1.2-1.6)3

    2.2

    (1.8-2.7)3

    Dronedarone 400 mg BID 10 mg 1.4

    Itraconazole 200 mg QD, 5 days 10 mg

    or

    80 mg

    1.4

    (1.2-1.6)3

    1.3

    (1.1-1.4)3

    1.4

    (1.2-1.5)3

    1.2

    (0.9-1.4)3

    Ezetimibe 10 mg QD, 14 days 10 mg QD for

    14 days

    1.2

    (0.9-1.6)3

    1.2

    (0.8-1.6)3

    Fosamprenavir/ritonavir 700 mg/100 mg BID for 7

    days 10 mg 1.1 1.5

    Fenofibrate 67 mg TID for 7 days 10 mg 1.2

  • 16

    (1.1-1.3)3

    Rifampicin 450 mg QD, 7 days 20 mg

    Aluminum & magnesium hydroxide combination

    antacid

    Administered simultaneously()

    Administered 2 hours apart( 2 )

    40 mg

    40 mg

    0.52

    (0.4-0.5)3

    0.8

    (0.7-0.9)3

    0.52

    (0.4-0.6)3

    0.8

    (0.7-1.0)3

    Ketoconazole 200 mg BID for 7 days 80 mg 1.0

    (0.8-1.2)3

    1.0

    (0.7-1.3)3

    Fluconazole 200 mg QD for 11 days 80 mg 1.1

    (1.0-1.3)3

    1.1

    (0.9-1.4)3

    Erythromycin 500 mg QID for 7 days 80 mg 0.8

    (0.7-0.9)3

    0.7

    (0.5-0.9)3 1.

    2. ((2)(5)) 3. 90% (/: 1=; 0.7= 30%; 11=11 6 Rosuvastatin Rosuvastatin

    (/)

    = 1.0

    AUC Cmax

    40 mg QD for 10 days Warfarin1

    25 mg single dose

    R-Warfarin

    1.0

    (1.0-1.1)2

    S-Warfarin

    1.1

    (1.0-1.1)2

    R-Warfarin

    1.0

    (0.9-1.0)2

    S-Warfarin

    1.0

    (0.9-1.1)2

    40 mg QD for 12 days Digoxin

    0.5 mg single dose

    1.0

    (0.9-1.2)2

    1.0

    (0.9-1.2)2

    40 mg QD for 28 days Oral Contraceptive

    (ethinyl estradiol 0.035 mg

    & norgestrel 0.180, 0.215

    and 0.250 mg) QD for 21

    EE 1.3

    (1.2-1.3)2

    NG 1.3

    (1.3-1.4)2

    EE 1.3

    (1.2-1.3)2

    NG 1.2

    (1.1-1.3)2

  • 17

    Days

    EE = ethinyl estradiol, NG = norgestrel

    1. ((5.3)) 2. 90% (/: 1=; 0.7= 30%; 11=11 12.5 HMG-CoA ( rosuvastatin) OATP1B1 n =35 rosuvastatin OATP1B1SLCO1B1 521T>C 2 (alleles) SLCO1B1 521 C/C/ 5% rosuvastatin / 13.

    13.1 104 rosuvastatin 22060 80 mg 80 mg ( AUC 40 mg 20 )

    107 rosuvastatin 1060 200 mg 200 mg ( AUC 40 mg 20 )/

    (Salmonella typhimurium)(Escherichia coli) Ames(the mouse lymphoma assay)(the chromosomal aberration assay)rosuvastatin Rosuvastatin (in vivo mouse micronucleus test)

    rosuvastatin 51550 mg 9 rosuvastatin 2 7 rosuvastatin rosuvastatin 50 mg ( AUC 40 mg 10 ) rosuvastatin 30 mg (spermatidic giant cells) rosuvastatin 30 mg

    40 mg 20 10 HMG-CoA

    13.2 /

    -

  • 18

    Rosuvastatin 16 rosuvastatin 25 mg rosuvastatin 3% 20% 18 rosuvastatin 1 mg( 25%)

    7 rosuvastatin 51550 mg( AUC 40 mg 10 )()

    7 21 () rosuvastatin 21050 mg 50 mg ( 40 mg 12 )

    6 18 () rosuvastatin 0.313 mg ( 40 mg)

    rosuvastatin 25 mg rosuvastatin 3 mg ( AUC 40 mg )

    HMG-CoA

    HMG-CoA 30 ([Wallerian degeneration of retinogeniculate fibers]) rosuvastatin 90 mg( AUC 40 mg 100 ) 24 (choroid plexus) rosuvastatin 6 mg( AUC 40 mg 20 ) 52 rosuvastatin 30 mg( AUC 40 mg 60 ) 12 rosuvastatin 90 mg( AUC 40 mg 100 ) 4 30 mg ( AUC 40 mg 60 )

    14.

    14.1 CRESTOR B

  • 19

    CRESTOR 6 B (7) 7. CRESTOR ( 6 )

    B

    13 -5 -7 -7 -3 -3 3

    5 17 -33 -45 -44 -38 -35 13

    10 17 -36 -52 -48 -42 -10 14

    20 17 -40 -55 -51 -46 -23 8

    40 18 -46 -63 -60 -54 -28 10

    2240 CRESTOR atorvastatinsimvastatinpravastatin HMG-CoA CRESTORatorvastatinsimvastatin pravastatin 6 ( 1 8) 1. 6 CRESTORAtorvastatinSimvastatin Pravastatin

    8. 6 (LS means 1) (156-167 )

    10 mg 20 mg 40 mg 80 mg

    CRESTOR -462 -523 -554 ---

    25 50 75 10 90

    189 mg/dL

  • 20

    Atorvastatin -37 -43 -48 -51 Simvastatin -28 -35 -39 -46 Pravastatin -20 -24 -30 --- 1. 1.00 2. CRESTOR 10 mg atorvastatin 10 mgpravastatin 10

    mg20 mg40 mgsimvastatin 10 mg20 mg40 mg (p0.002) 3. CRESTOR 20 mg atorvastatin 20 mg40 mg

    pravastatin 20 mg40 mgsimvastatin 20 mg40 mg80 mg (p0.002) 4. CRESTOR 40 mg atorvastatin 40 mgpravastatin 40

    mgsimvastatin 40 mg80 mg (p0.002) 14.2 ( 291) CRESTOR 20 mg atorvastatin 20 mg 6 ( 9) 9. CRESTOR

    (n=435)

    LS Means 1 (95% CI)

    Atorvastatin

    (n=187)

    LS Means1 (95% CI)

    6 20 mg -47% (-49%, -46%) -38% (-40%, -36%)

    12 40 mg -55% (-57%, -54%) -47% (-49%, -45%)

    18 80 mg NA -52% (-54%, -50%)

    1. LS Means 14.3 - 273-817 mg/dL CRESTOR (5-40 mg) 6 ( 10) 10. CRESTOR 6

    ()

    N=26

    CRESTOR

    5 mg

    N=25

    CRESTOR

    10 mg

    N=23

    CRESTOR

    20 mg

    N=27

    CRESTOR

    40 mg

    N=25

    1 (-40, 72) -21 (-58, 38) -37 (-65, 5) -37 (-72, 11) -43 (-80, -7)

    2 (-13, 19) -29 (-43, -8) -49 (-59, -20) -43 (-74, -12) -51 (-62, -6)

    2 (-36, 53) -25 (-62, 49) -48 (-72, 14) -49 (-83, 20) -56 (-83, 10)

    1 (-13, 17) -24 (-40, -4) -40 (-51, -14) -34 (-61, -11) -40 (-51, -4)

    5 (-30, 52) -28 (-71, 2) -45 (-59, 7) -31 (-66, 34) -43 (-61, -3)

    -3 (-25, 18) 3 (-38, 33) 8 (-8, 24) 22 (-5, 50) 17 (-14, 63)

  • 21

    14.4 (III ) 32 (III )(27 2/24 E [Arg145Cys]) 6 NCEP (TLC) 6 TLC rosuvastatin 10 mg rosuvastatin 20 mg rosuvastatin 20 mg rosuvastatin 10 mgCRESTOR()

    11. (III ) Rosuvastatin 10mg 20 mg 6 (95% CI) (N=32)

    (mg/dL)

    (95% CI)

    CRESTOR 10 mg

    (95% CI)

    CRESTOR 20 mg

    342.5 -43.3

    (-46.9,-37.5)

    -47.6

    (-51.6,-42.8)

    503.5 -40.1

    (-44.9, -33.6)

    -43.0

    (-52.5, -33.1)

    294.5 -48.2

    (-56.7, -45.6)

    -56.4

    (-61.4, -48.5)

    +

    209.5 -46.8

    (-53.7, -39.4)

    -56.2

    (-67.7, -43.7)

    112.5 -54.4

    (-59.1, -47.3)

    -57.3

    (-59.4, -52.1)

    35.5 10.2

    (1.9, 12.3)

    11.2

    (8.3, 20.5)

    (RLP-C)

    82.0 -56.4

    (-67.1, -49.0)

    -64.9

    (-74.0, -56.6)

    E (Apo E) 16.0 -42.9

    (-46.3, -33.3)

    -42.5

    (-47.1, -35.6)

    14.5 6 40 (n=408-63 ) CRESTOR 20-40 mg 22% 20 mg 40 mg 6% 27 15%

  • 22

    30%( 28%) 13 15% 3 5 3 15% 14.6 12 176 (97 79 ) 510 20 mg rosuvastatin 10-17 ( 13 ) 30% 10-13 17%18%40% 25% Tanner IIIIIIV V 233 mg/dL (129-399) 12 40 (n=173) 5 mg10 mg 20 mg rosuvastatin rosuvastatin () B 12 12 Rosuvastatin 10-17(

    12 )

    (mg) N

    1

    B

    46 -1% +7% 0% -7% -2%

    5 42 -38% +4%2 -30% -13%2 -32%

    10 44 -45% +11%2 -34% -15% 2 -38%

    20 44 -50% +9%2 -39% -16% 2 -41%

    1.

    2. 12 110 mg/dL (2.8 mmol/L) 0%rosuvastatin 5 mg 12%rosuvastatin 10 mg 41%rosuvastatin 20 mg 41% 40 71% 20 mg 41% 110 mg/dL

    rosuvastatin 14.7 METERO study

  • 23

    (Intima Media Thickness) CRESTOR 40mg (METEOR)(Framingham risk

  • 24

    23782390

    Crestor is a trademark of the AstraZeneca group of companies AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom